Latest News about JNJ
Recent news which mentions JNJ
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
From Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
From Benzinga
Looking At Johnson & Johnson's Recent Unusual Options Activity
September 27, 2023
Tickers
JNJ
From Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
September 27, 2023
From Motley Fool
This Is the Holy Grail of Investing
September 26, 2023
From InvestorPlace
2 Monster Stocks to Buy Without Any Hesitation
September 26, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
From Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
September 20, 2023
From Motley Fool
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
September 20, 2023
From Motley Fool
3 No-Brainer Stocks to Buy With $500 Right Now
September 20, 2023
From Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
September 19, 2023
From InvestorPlace
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
September 17, 2023
From Motley Fool
3 Great Dividend Stocks You Can Buy for Less Than $50
September 15, 2023
From Motley Fool
From Benzinga
The 3 Most Undervalued Dow Stocks to Buy in September 2023
September 15, 2023
From InvestorPlace
Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations
September 14, 2023
From Benzinga
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
September 14, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
From Benzinga
3 Warren Buffett Stocks That Are Near Their 52-Week Lows
September 14, 2023
From Motley Fool
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
September 13, 2023
From InvestorPlace
Here's My Top Growth Stock to Buy in 2023
September 13, 2023
From Motley Fool
Better Buy: J&J vs. Kenvue
September 13, 2023
From Motley Fool
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
From Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
From Benzinga
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
From Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Here’s an easy way to make a more concentrated play on the ‘Magnificent Seven’ stocks
September 11, 2023
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.